Post-Conference Perspectives: CD19-directed CAR-T Cell Therapy in Lymphomas - Episode 5
Selecting the Appropriate CAR T-Cell Therapy for Patients with R/R LBCL
Marc S. Hoffman, MD, explains how to select the appropriate CAR T-cell therapy for each patient, and the barriers patients with R/R LBCL face in receiving CAR T-cell therapy, despite its high efficacy rate.
Related Content:
